Vanguard Group Inc Paratek Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.37 - $2.54 $39,617 - $73,451	28,918 Added 1.31%	2,228,066 $5.66 Million
Q4 2022 Feb 10, 2023	BUY	$1.67 - $2.51 $40,953 - $61,552	24,523 Added 1.13%	2,199,148 $4.11 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $303,680 - $453,971	154,939 Added 7.67%	2,174,625 $5.59 Million
Q2 2022 Aug 12, 2022	SELL	$1.73 - $3.09 $448,402 - $800,903	-259,192 Reduced 11.37%	2,019,686 $3.9 Million
Q1 2022 May 13, 2022	BUY	$2.94 - $4.77 $344,288 - $558,590	117,105 Added 5.42%	2,278,878 $6.77 Million
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $183 - $238	-45 Reduced -0.0%	2,161,773 $9.71 Million
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $53,095 - $81,790	11,297 Added 0.53%	2,161,818 $10.5 Million
Q2 2021 Aug 13, 2021	BUY	$6.81 - $10.93 $14.6 Million - $23.5 Million	2,150,521 New	2,150,521 $14.7 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.